Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombosis in pregnancy

S M Bates1, J S Ginsberg

  • 1McMaster University Medical Centre, Hamilton, Ontario, Canada.

Current Opinion in Hematology
|September 1, 1997
PubMed
Summary
This summary is machine-generated.

Pregnancy increases the risk of venous thromboembolism, requiring careful diagnosis and management. This review covers risk factors, diagnosis, treatment, and prevention strategies for blood clots during pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physicochemical and functional assessment of messenger RNA 5'Cap-end impurities under forced degradation conditions.

Molecular therapy. Nucleic acids·2025
Same author

COVID-19 in thrombosis research: An editorial perspective.

Thrombosis research·2021
Same author

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: reply.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Once versus twice daily aspirin after coronary bypass surgery: a randomized trial.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies.

Journal of thrombosis and haemostasis : JTH·2016
Same author

D-dimer levels and recurrence in patients with unprovoked VTE and a negative qualitative D-dimer test after treatment.

Thrombosis research·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Cardiology

Background:

  • Thrombosis during pregnancy presents unique clinical challenges.
  • Venous thromboembolism (VTE) is a significant concern in pregnant individuals.
  • Antiphospholipid antibodies add complexity to VTE management in pregnancy.

Purpose of the Study:

  • To review risk factors for VTE in pregnancy.
  • To outline diagnostic approaches for deep vein thrombosis (DVT) and pulmonary embolism (PE) in pregnant patients.
  • To discuss therapeutic strategies for acute VTE and thromboprophylaxis in pregnancy, including management of antiphospholipid antibodies.

Main Methods:

  • Literature review focusing on VTE in pregnancy.
  • Synthesis of current evidence on risk factors, diagnosis, and management.

Related Experiment Videos

  • Analysis of treatment recommendations and prophylactic measures.

    • Main Results:

    • Pregnancy is an independent risk factor for VTE.
    • Diagnostic challenges exist due to physiological changes and imaging limitations.
    • Anticoagulation is the cornerstone of VTE treatment and prevention, with specific considerations for pregnant women.

    Conclusions:

    • Comprehensive understanding of VTE risk factors and diagnostic tools is crucial for pregnant patients.
    • Tailored therapeutic and prophylactic strategies are essential for managing VTE in pregnancy.
    • Special attention is required for pregnant individuals with antiphospholipid antibodies to optimize outcomes.